Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
<a href="https://pixabay.com/users/stevepb/">stevepb</a> / Pixabay

Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…

Continue Reading
FDA Grants Regenerative Medicine Advanced Therapy Designation to Experimental Wiskott-Aldrich Syndrome Drug
<a href="https://pixabay.com/users/stevepb/">stevepb</a> / Pixabay

FDA Grants Regenerative Medicine Advanced Therapy Designation to Experimental Wiskott-Aldrich Syndrome Drug

According to a press release from the British-American biopharmaceutical company Orchard Therapeutics, the American Food and Drug Administration (FDA) has granted OTL-103, the Company's experimental Wiskott-Aldrich Syndrome drug, Regenerative Medicine…

Continue Reading
Close Menu